Refika Yigit
Groningen, GR, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Later age of natural menopause among women with the pathogenic CHEK2 c.1100delC variant: a validation study.
Journal: Journal of medical genetics
Published: October 30, 2025
Development of cardiovascular risk factors in women with a BRCA1/2 pathogenic variant within five years after tubo-ovarian cancer risk reduction in the TUBA study.
Journal: Maturitas
Published: August 12, 2025
Evaluation of the recently established Dutch nationwide Archipelago of Ovarian Cancer Research biobank.
Journal: Annals of diagnostic pathology
Published: October 12, 2024
High-grade serous carcinoma occurring after risk-reducing salpingo-oophorectomy in BRCA1/2 germline pathogenic variant carriers.
Journal: Journal of the National Cancer Institute
Published: September 25, 2024
Vvax001, a Therapeutic Vaccine, for Patients with HPV16-Positive High-grade Cervical Intraepithelial Neoplasia: A Phase II Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 25, 2024
Hormone Receptor Expression and Activity for Different Tumour Locations in Patients with Advanced and Recurrent Endometrial Carcinoma.
Journal: Cancers
Published: April 15, 2024
Long-term outcome of high-grade serous carcinoma established in risk-reducing salpingo-oophorectomy specimens in asymptomatic BRCA1/2 germline pathogenic variant carriers.
Journal: Gynecologic oncology
Published: March 18, 2024
Neoadjuvant immune checkpoint blockade in women with mismatch repair deficient endometrial cancer: a phase I study.
Journal: Nature communications
Published: February 23, 2024
B cells critical for outcome in high grade serous ovarian carcinoma.
Journal: International journal of cancer
Published: December 20, 2023
Optimising follow-up strategy based on cytology and human papillomavirus after fertility-sparing surgery for early stage cervical cancer: a nationwide, population-based, retrospective cohort study.
Journal: The Lancet. Oncology
Published: June 22, 2023
The risk of lymph node metastasis in the new FIGO 2018 stage IA cervical cancer with >7 mm diameter.
The risk of lymph node metastasis in the new FIGO 2018 stage IA cervical cancer with >7 mm diameter.
Journal: Journal of gynecologic oncology
Published: November 28, 2022
Last Updated: 09/26/2026